Precigen
PGEN
$1.41
Share price
0.71%
Change (1 day)
16.53%
Change (1 year)
Categories
Precigen (PGEN) - Cash on Hand
Cash on Hand as of December 2023 : $62.85 M
According to Precigen's latest financial reports the company has $62.85 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Precigen - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $55.95 M | -48.51% |
| 2021-12-31 | $0.10 B | 8.54% |
| 2020-12-31 | $0.10 B | 33.4% |
| 2019-12-31 | $75.05 M | -65.39% |
| 2018-12-31 | $0.21 B | 172.22% |
| 2017-12-31 | $79.66 M | -66.41% |
| 2016-12-31 | $0.23 B | -0.46% |
| 2015-12-31 | $0.23 B | 105.51% |
| 2014-12-31 | $0.11 B | -34.67% |
| 2013-12-31 | $0.17 B | 1564.53% |
| 2012-12-31 | $10.66 M | -46.38% |
| 2011-12-31 | $19.88 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $5.29 M | -91.58% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | 99.53% | 🇬🇧 UK |
 Novavax NVAX | $0.56 B | 804.47% | 🇺🇸 USA |
 Novocure
NVCR | $0.91 B | 1,348.76% | Jersey |